Press Release - eMatrix™ Sublative Rejuvenation™ System by Syneron Recently Received FDA Clearance for Expanded Indications


For Release:

July 2010

FOR IMMEDIATE RELEASE
CONTACT: Suzanne Lombardo, Business Director
(847) 459-6400

eMatrix™ Sublative Rejuvenation™ System by Syneron Recently Received FDA Clearance for Expanded Indications

Indication for Fine Line and Wrinkle Treatment Expands Product Versatility

Lincolnshire, IL – July 2010 – Syneron Medical, Ltd. recently announced the expanded FDA approval for the eMatrix™ Sublative Rejuvenation™ system. The expanded clearance of the Matrix RF handpiece on the eMatrix system that performs Sublative Rejuvenation is for the treatment of fine lines and facial wrinkles.

Dr. Amy Forman Taub, board-certified dermatologist, owner and Medical Director of Advanced Dermatology in Lincolnshire, IL and Assistant Clinical Professor at Northwestern University Medical School led the research effort. She noted, “In our clinical study we have found those patients treated with the eMatrix system received a safe, tolerable and effective improvement in skin texture and reduction of wrinkles. The depth of tissue ablation and coagulation, and the relative proportions of these phenomena were found to be controllable and could be modulated to optimize treatment of variable dermatologic conditions.”

The eMatrix is the world’s first RF-only technology for fractional ablation(skin resurfacing) on the market. It treats minute skin areas, leaving the surrounding untreated skin areas intact to act as healing reservoirs for the thermally damaged tissue. The undamaged tissue promotes quicker healing and ensures limited patient downtime while speeding the appearance of desired results. The tunable eMatrix applicator is equipped with the SelectPulse™ to enable customization of the depth of ablation and degree of skin resurfacing based on individual patient needs. Three different modalities can be emulated due to this software and technology: erbium glass fractional resurfacing, carbon dioxide fractional resurfacing and YSGG fractional resurfacing. An average of 3-5 treatments is recommended to achieve optimal results. Tissue tightening and smoothness may continuing to develop for up to six months post treatment.

Dr. Amy Forman Taub founded Advanced Dermatology, Skinfo® Specialty Skincare Boutique and SKINQRI in Lincolnshire, Illinois. Advanced Dermatology is a state-of-the-art medical and cosmetic dermatology practice nationally recognized for excellence in dermatologic care. Skinfo and skinfo.com, a professional skincare website, offer physician-dispensed and cosmeceutical-grade skincare products and product information to the public. In 2006, Dr. Taub founded SKINQRI, Advanced Research in Dermatology. SKINQRI collaborates with pharmaceutical and laser companies to test the safety and efficacy of new treatments and evaluate new protocols for current treatments. Dr. Taub's practice philosophy is one of active collaboration with her patients. While she likes being on the cutting edge of technological and medical innovations, Dr. Taub carefully evaluates the scientific principles and safety of new treatments and procedures she makes available to her patients.

Born and raised in the Chicago area, Dr. Taub graduated from Northwestern University Medical School in 1985 and completed her internal medicine internship and dermatology residency at its affiliated hospital, Northwestern Memorial, in 1989. Prior to opening Advanced Dermatology, Dr. Taub was the Medical Director for the Division of Dermatology of Northwestern Memorial Physicians Group.

As a consultant to leading laser and drug companies, Dr. Taub also educates and trains physicians from all over the country to provide cosmetic and laser procedures. Dr. Taub is a member (Fellow) of the American Academy of Dermatology (AAD), the American Society for Dermatologic Surgery (ASDS), the American Society for Laser Surgery and Medicine (ASLMS), the Chicago Dermatologic Society, and the Illinois State Dermatologic Society. Dr. Taub is also a Charter Board of Director for the American Society of Photodynamic Therapy (ASPDT), a member of the Leaders Society to the Dermatology Foundation, on the Advisory Council of the Skin Cancer Foundation, and on the Research Committee for the ASDS.


Advanced Dermatology
275 Parkway Drive Suite 521 Lincolnshire, IL 60069
(847) 459 6400
www.advdermatology.com
slombardo@advdermatology.com